Spread Pricing: The PBM Fee Hiding in Plain Sight
Navitus frames this issue in a useful way. Navitus explains spread pricing and how it can affect plan costs.
For employers, the value is not the definition. The value is what the definition changes before the company signs another renewal.
Spread pricing is simple: the PBM pays one amount to the pharmacy and charges the plan another. The difference can become hidden margin.
Why This Matters To The Business
The invoice says the claim was paid. It does not always show who kept the spread.
That moment shows the real problem. The plan may be expensive, but the bigger issue is often that nobody can explain the machinery underneath it.
For the CEO, this connects to margin, hiring, retention, and risk. Ask why a middleman should profit more when the drug claim is less clear.
For the CFO, this connects to cash flow and control. Ask for pharmacy claim-level reporting that shows ingredient cost, dispensing fee, admin fee, rebate, and spread.
The Practical Review
Put the current plan, contract, or renewal proposal on the table. Then ask:
- Who keeps manufacturer rebates?
- Is pricing pass-through, spread, or something dressed up as both?
- Can you audit claims, rebates, and formulary decisions?
Do not accept a vague answer. Do not accept a slide that looks good but leaves the decision unclear. Ask for the document, the number, and the person who owns the next step.
What Good Looks Like
Pharmacy costs are often where opacity hides. Discount language can sound impressive while rebates, spread, formulary choices, and admin fees move money away from the plan.
A transparent PBM conversation should show net cost, who keeps what, what can be audited, and how the contract rewards lower plan spend.
What I would want in the file:
- Rebate flow statement
- Spread or pass-through pricing proof
- Audit rights and formulary review rules
That file does two jobs. It helps leadership make a better decision now. It also creates a record that shows the company acted with care later.
This is the gap I see most often. The employer may have a smart person in HR, a broker presentation, and a spreadsheet. But nobody has a clean decision file. When pressure hits, the company has memories instead of proof.
In a live plan review, I would not start with a recommendation. I would start with the current document set and the last renewal decision. Then I would compare what the company thought it bought against what the contract actually says. That gap is usually where the money hides.
What To Do Before Renewal
Pick ten high-cost pharmacy claims and trace the money from pharmacy to PBM to plan.
This is where proactive strategy beats reactive shopping. Renewal season should not be the first time leadership sees the risk. It should be the point where a prepared team confirms the path.
The Warning Sign
If the PBM will not show the spread, assume the spread matters.
That warning sign is not small. It tells you whether the plan is governed or merely renewed.
Save this line: If the PBM will not show the spread, assume it matters.
The rules are changing. The exposure is real. The opportunity is massive for employers that move early.
Book 15 minutes at www.Paul.Health if you want this reviewed against your current plan.